After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
PACL: No one is authorized to sell PACL properties, documents can be submitted till August 31
The SEBI panel on Monday cautioned the public that it has not given any responsibility to sell th
During a secretary-level meeting on the status of COVID-19 in the country, a senior central gover
Exports: Exports up 23.5 percent, trade deficit widens to a record $ 26.18 billion
The country's exports of goods have increased by 23.52 percent to $ 40.13 billion in June 2022. I
Buy 43 Inch Best Selling 4K Ultra HD Smart TV in Offer Only Rs.24k
Redmi Smart TV On Amazon: If you want to get a medium size TV in a low budget, on which you enjoy
Ranveer Singh and Alia Bhatt's starrer film 'Rocky Aur Rani Ki Prem Kahani' is in the limelight b
Not only are private coaching centers charging huge amounts from students, but many other questio
On Sunday evening, only one name echoed in the R Premadasa Cricket Stadium in Colombo and that na
The new Pirola variant of Corona is less infectious in American laboratories. Research has been d
After shirtless agitation, offering roses to ministers, and going on hunger strike, unemployed yo
Uproar over Imran's Uteron on Sugar-cotton imports from India; PAK businessmen say - will be ruined
Pakistan is finding it expensive to take Uteron on the decision to approve the import of sugar an
